Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Manning & Napier Advisors LLC Decreases Position in Bristol Myers Squibb Company $BMY
LJI Wealth Management LLC Takes $2.11 Million Position in Bristol Myers Squibb Company $BMY
Drucker Wealth 3.0 LLC Makes New $1.12 Million Investment in Bristol Myers Squibb Company $BMY - Daily Political
Bristol Myers Squibb accused of buying off competitors to delay development of generic cancer drugs
Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Pharma Sector Sentiment Shift Accurately
GRIMES & Co WEALTH MANAGEMENT LLC Sells 28,024 Shares of Bristol Myers Squibb Company $BMY - Zolmax
GRIMES & Co WEALTH MANAGEMENT LLC Reduces Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Bought by Generali Asset Management SPA SGR
Bristol Myers Squibb Company $BMY Stock Position Raised by RFG Advisory LLC - Stock Observer
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial
The Agencies Building Pharma's Next Decade Just Picked Their Software: Daily Command Launches With 18 of the Industry's Most Senior Agency Leaders Already Inside It
Premier Fund Managers Ltd Invests $11.63 Million in Bristol Myers Squibb Company $BMY
IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi Leading
Principal Financial Group Inc. Reduces Stake in Bristol Myers Squibb Company $BMY
6 Pharma Dividend Stocks Yielding Up to 6.44% - and They've Survived Every Market Crash
Bokf Na Reduces Stock Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by RNC Capital Management LLC
Truist Financial Corp Trims Stake in Bristol Myers Squibb Company $BMY
Pinnacle Wealth Management Advisory Group LLC Increases Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer
Bristol Myers Squibb Company $BMY Shares Bought by Intact Investment Management Inc. - Stock Observer
Christine Messmer PC Makes New Investment in Bristol Myers Squibb Company $BMY - Stock Observer
In FIFA-Tied Corporate Campaign, Bristol Myers Squibb 'Won't Lose' 05/05/2026
Seizert Capital Partners LLC Acquires 38,725 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Launches "Won't Lose" Media Campaign Ahead of FIFA World Cup 2026™
M&T Bank Corp Purchases 13,307 Shares of Bristol Myers Squibb Company $BMY - Daily Political
Bristol Myers beats quarterly profit estimates on blood thinner, cancer drug sales
A Look At Bristol Myers Squibb (BMY) Valuation After Its Q1 2026 Earnings Beat And Reaffirmed Guidance
BMY: Upcoming Late Stage Readouts Will Drive Potential Re Rating Opportunity
Scotiabank Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY) | Markets Insider
Bristol Myers Squibb Company $BMY Shares Bought by CX Institutional
Bristol Myers Squibb Company (NYSE:BMY) Given Average Recommendation of "Hold" by Brokerages - Zolmax
Strs Ohio Sells 46,600 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Robertson Stephens Wealth Management LLC Increases Stake in Bristol Myers Squibb Company $BMY - Stock Observer
Bristol Myers Squibb Q1 Earnings Call Highlights - Zolmax
Bristol Myers Squibb (BMY) Margin Strength In Q1 2026 Challenges Bearish Earnings Narratives
Bristol Myers Squibb Company $BMY Shares Sold by Danske Bank A S
GC Wealth Management RIA LLC Reduces Stake in Bristol Myers Squibb Company $BMY
PFA Pension Forsikringsaktieselskab Makes New Investment in Bristol Myers Squibb Company $BMY - Stock Observer
Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 - Data Talk | Morningstar
Big Pharma M&A set for mega year as patent expiries drive deal urgency
Bristol-Myers Squibb Company (NYSE:BMY) Q1 2026 Earnings Call Transcript
Bristol Myers Squibb Company $BMY Shares Sold by New York State Teachers Retirement System
Is Bristol Myers Squibb (BMY) Still Attractively Priced After Its Strong 1 Year Share Price Gain
Bristol Myers Squibb Q1 Earnings Call Highlights
US Bancorp DE Sells 119,454 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Bristol-Myers Squibb Co (BMY) Q1 2026 Earnings Call Highlights: Navigating Growth and ...
BMY SWOT Analysis: Financial Resilience Amidst Market Challenges Revealed in 10-Q Filing
GenTrust LLC Takes $778,000 Position in Bristol Myers Squibb Company $BMY - Daily Political
Bristol Myers Squibb (NYSE:BMY) Posts Quarterly Earnings Results, Beats Expectations By $0.12 EPS
Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients
Is Bristol-Myers Squibb Co (BMY) Overvalued After 5.2% Rally? GF Value Says Overvalued
Bristol Myers Squibb (NYSE:BMY) Issues Quarterly Earnings Results - Daily Political
Bristol Myers Squibb Company $BMY Shares Sold by Verity Asset Management Inc.
BMY Forecasts Strong Growth with FY26 Revenue Projections
AI in Clinical Development Summit to Showcase Life Sciences and Technology Leaders Driving Real-World AI Impact | Morningstar
Bristol Myers Squibb (BMY) Q1 2026: EPS $1.31 Beats $1.19 Est., Revenue $11.49B Tops $10. ...
Bristol Myers Squibb Reports First Quarter Financial Results for 2026 | Morningstar
A Look At Bristol Myers Squibb (BMY) Valuation After Upbeat 2026 Guidance And Cost-Cutting Progress
Resolving sensitivity, specificity and signal contamination in Xenium spatial transcriptomics
Wealthfront Advisers LLC Acquires 21,704 Shares of Bristol Myers Squibb Company $BMY
Do Wall Street Analysts Like Bristol-Myers Squibb Stock?
Bristol Myers Squibb Company $BMY Shares Sold by Fagan Associates Inc. - Daily Political
Does Expanded MTAP-CDx Partnership With Foundation Medicine Change The Bull Case For Bristol-Myers Squibb (BMY)?
Evolutionary characterization of lung cancer metastasis
Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1
ISM® Honors Farryn Melton with 2026 J. Shipman Gold Medal Award | Morningstar
Bristol Myers Squibb Company $BMY Shares Sold by Skylands Capital LLC
Mitsubishi UFJ Trust & Banking Corp Trims Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Stock Position Reduced by R Squared Ltd
Comerica Bank Decreases Stake in Bristol Myers Squibb Company $BMY
D.A. Davidson & CO. Purchases 28,410 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages
BMS patents Ikaros family zinc finger protein degradation inducers | BioWorld
The clinical landscape of HIF2α inhibitors in oncology
Is Bristol Myers Squibb the Best Bargain in Big Pharma?
Aprio Wealth Management LLC Buys 44,125 Shares of Bristol Myers Squibb Company $BMY
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study
Vanguard Group Inc. Grows Stock Holdings in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Acquired by Chicago Partners Investment Group LLC
Advisors Capital Management LLC Raises Stake in Bristol Myers Squibb Company $BMY
Bristol-Myers Squibb Precision Oncology Deal Meets Mixed Valuation Signals
Pfizer Tests Transparent Eliquis Pricing As Valuation Signals Undervaluation
Pfizer Eliquis Price Move With Cost Plus Raises Questions On Valuation
First Interstate Bank Sells 52,361 Shares of Bristol Myers Squibb Company $BMY
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
Assessing Bristol Myers Squibb (BMY) Valuation After Recent Earnings Compression And Growth Portfolio Performance
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy
Bristol Myers, Pfizer Bring Eliquis to Cost Plus at $345 Monthly
Bristol-Myers Squibb Company (BMY): Favorite for Conservative Portfolios
Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy
Kerusso Capital Management LLC Purchases 12,988 Shares of Bristol Myers Squibb Company $BMY - Markets Daily
BristolMyers News
FTSE 100 Surges Past 10,000 Milestone: What It Means for UK Investors in 2026 Amid Global Volatility?
Oil Price Analysis: UAE Oil Revenues Surge on High Brent Prices Despite Hormuz Disruptions and Production Volatility
Why Intel ($INTC) Stock Is Surging 217% YTD: Apple Chip Deal, Trump Admin’s Investment, Elon Musk Partnership
Strong Dirham Continues to Hold Firm: What’s the AED to PKR Exchange Rate Today?
Forex market today: Australian Dollar outlook, why is the Aussie dollar so strong?
DOGE/EGP Slips as Dogecoin Faces Selling Pressure: Is It a Good Time to Buy Dogecoin in Egypt?
How to trade CFDs in Australia: Gold CFDs, Crypto CFDs, Forex CFDs and More
Latest news
Show more
Gold Price Today, May 09: Gold (XAUUSD) at $4,720 Faces Correction Risk After 250% Rally as Oil Leads Markets
Tata Gold ETF Rides XAUUSD Breakout as Middle East Developments Shake Markets
Gold Price Today, May 08: XAUUSD Surge to $4,753 on Easing Oil and Inflation Signals
Crypto Market News Today: Dogecoin DOGEUSD Surges Past $0.115 as Meme Coin Momentum Builds in 2026
Gold Price Today, May 07: XAU/USD Soars 2.73% to Record $4,685 Amid Market Rally
